| Literature DB >> 25584835 |
Do Thi Ha1, Le Thi Loan2, Tran Manh Hung3, Le Vu Ngoc Han4, Nguyen Minh Khoi5, Le Viet Dung6, Byung Sun Min7, Nguyen Phuong Dai Nguyen8.
Abstract
An HPLC-DAD method for the quality control of wild and cultivated Ganoderma lucidum (Linhzhi) and related species samples was developed and validated. The quantitative determination of G. lucidum and its related species using 14 triterpene constituents, including nine ganoderma acids (compounds 4-12), four alcohols (compounds 13-16), and one sterol (ergosterol, 17) were reported. The standard curves were linear over the concentration range of 7.5-180 µg/mL. The LOD and LOQ values for the analyses varied from 0.34 to 1.41 µg/mL and from 1.01 to 4.23 µg/mL, respectively. The percentage recovery of each reference compound was found to be from 97.09% to 100.79%, and the RSD (%) was less than 2.35%. The precision and accuracy ranged from 0.81%-3.20% and 95.38%-102.19% for intra-day, and from 0.43%-3.67% and 96.63%-103.09% for inter-day, respectively. The study disclosed in detail significant differences between the quantities of analyzed compounds in different samples. The total triterpenes in wild Linhzhi samples were significantly higher than in cultivated ones. The total constituent contents of the five related Linhzhi samples were considerably lower than that in the G. lucidum specimens, except for G. australe as its constituent content outweighed wild Linhzhi's content by 4:1.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25584835 PMCID: PMC6272446 DOI: 10.3390/molecules20011059
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical compounds 1–17 isolated from G. lucidum.
Retention time reproducibilities, regression equations, correlation coefficients (r2), F-test, p (F), linearity ranges, LOD, and LOQ of the compounds 4–17 (n = 8).
| Compounds | Retention Time Reproducibility (min, | Regression Equation | *F | *p (F) | Linearity Range (μg/mL) | LOD (μg/mL) | LOQ (μg/mL) | |
|---|---|---|---|---|---|---|---|---|
| Lucidenic acid N ( | 48.176 ± 0.110 | 0.9999 | 12.67 | 0.00314 | 7.50–180.00 | 0.88 | 2.64 | |
| Lucidenic acid E2 ( | 56.463 ± 0.161 | 0.9999 | 12.74 | 0.00308 | 7.50–180.00 | 0.82 | 2.45 | |
| Ganoderic acid A ( | 74.075 ± 0.130 | 0.9999 | 12.77 | 0.00305 | 7.50–180.00 | 0.34 | 1.01 | |
| Ganoderic acid E ( | 83.898 ± 0.240 | 0.9999 | 12.60 | 0.00320 | 7.50–180.00 | 1.17 | 3.52 | |
| Methyl lucidenate E2 ( | 93.330 ± 0.083 | 0.9999 | 12.59 | 0.00321 | 7.50–180.00 | 0.91 | 2.74 | |
| Methyl lucidenate A ( | 97.480 ± 0.080 | 0.9999 | 12.74 | 0.00308 | 7.50–180.00 | 0.68 | 2.04 | |
| Butyl lucidenate E2 ( | 101.827 ± 0.116 | 0.9999 | 12.65 | 0.00316 | 7.50–180.00 | 1.10 | 3.31 | |
| Lucidadiol ( | 104.729 ± 0.115 | 0.9999 | 12.74 | 0.00308 | 7.50–180.00 | 0.57 | 1.72 | |
| Ganodemanontriol ( | 105.589 ± 0.213 | 0.9999 | 13.89 | 0.00226 | 7.50–180.00 | 1.39 | 4.18 | |
| Ganoderiol F ( | 111.230 ± 0.245 | 0.9999 | 12.25 | 0.00353 | 7.50–180.00 | 1.41 | 4.23 | |
| Ganodermadiol ( | 121.772 ± 0.258 | 0.9999 | 12.70 | 0.00311 | 7.50–180.00 | 1.37 | 4.12 | |
| Ergosterol ( | 128.915 ± 0.267 | 0.9999 | 12.77 | 0.00306 | 7.50–180.00 | 0.94 | 2.82 | |
* F-test and p (F) values were analysed by one-way analysis of variance (ANOVA using the Origin V7.5 software (Originlab, Northampton, MA, USA). Statistical significance was assumed at below the 0.05 probability level.
Figure 2Chromatographic fingerprints of Ganoderma species. (A) the wild collected Linhzhi group (Group A); (B) the cultivated Linhzhi group (Group B); (C) the related Linhzhi species group (Group C). Compounds 1–17 were isolated from Ganoderma lucidum from the previous studies.
Recovery rates of the compounds 4–17 from extracts of G. lucidum.
| Compounds | Added (µg/mL) | Detected (µg/mL) | Recovery (%) | M ± SD (%) | RSD (%) |
|---|---|---|---|---|---|
| Lucidenic acid N ( | 9.50 | 9.47 | 99.68 | 99.51 ± 1.48 | 1.49 |
| 19.00 | 19.17 | 100.89 | |||
| 38.00 | 37.22 | 97.95 | |||
| Lucidenic acid E2 ( | 10.20 | 10.23 | 100.29 | 98.44 ± 1.61 | 1.64 |
| 20.40 | 19.92 | 97.65 | |||
| 40.80 | 39.73 | 97.38 | |||
| Ganoderic acid A ( | 10.40 | 10.21 | 98.17 | 98.71 ± 1.23 | 1.25 |
| 20.80 | 20.35 | 97.84 | |||
| 41.60 | 41.65 | 100.12 | |||
| Ganoderic acid E ( | 10.80 | 10.54 | 97.59 | 99.20 ± 1.45 | 1.46 |
| 21.60 | 21.69 | 100.42 | |||
| 43.20 | 43.02 | 99.58 | |||
| Methyl lucidenate E2 ( | 10.00 | 10.28 | 102.80 | 100.79 ± 1.74 | 1.73 |
| 20.00 | 19.95 | 99.75 | |||
| 40.00 | 39.93 | 99.83 | |||
| Methyl lucidenate A ( | 10.10 | 9.82 | 97.23 | 98.39 ± 1.76 | 1.79 |
| 20.20 | 19.70 | 97.52 | |||
| 40.40 | 40.57 | 100.42 | |||
| Butyl lucidenate E2 ( | 10.10 | 9.93 | 98.32 | 97.52 ± 1.95 | 2.00 |
| 20.20 | 19.25 | 95.30 | |||
| 40.40 | 39.97 | 98.94 | |||
| Lucidadiol ( | 10.50 | 10.12 | 96.38 | 97.17 ± 2.28 | 2.35 |
| 21.00 | 20.03 | 95.38 | |||
| 42.00 | 41.89 | 99.74 | |||
| Ganodemanontriol ( | 10.20 | 10.12 | 99.22 | 99.32 ± 1.27 | 1.27 |
| 20.40 | 20.53 | 100.64 | |||
| 40.80 | 40.03 | 98.11 | |||
| Ganoderiol F ( | 10.40 | 10.05 | 96.63 | 97.09 ± 1.12 | 1.15 |
| 20.80 | 20.46 | 98.37 | |||
| 41.60 | 40.05 | 96.27 | |||
| Ganodermadiol ( | 10.00 | 9.94 | 99.40 | 99.45 ± 1.63 | 1.63 |
| 20.00 | 20.22 | 101.10 | |||
| 40.00 | 39.14 | 97.85 | |||
| Ergosterol ( | 10.40 | 10.07 | 96.83 | 97.70 ± 2.21 | 2.26 |
| 20.80 | 19.98 | 96.06 | |||
| 41.60 | 41.69 | 100.22 | |||
Intraday and interday repeatability of 4–17.
| Compounds | Nominal Conc. (µg/mL) | Inter-Day | Intra-Day | ||||
|---|---|---|---|---|---|---|---|
| Observed Conc. (M ± SD), (μg/mL) | Accuracy (%) | Precision (%) | Observed Conc. (M ± SD), (μg/mL) | Accuracy (%) | Precision (%) | ||
| Lucidenic acid N | 30.25 | 30.02 ± 0.13 | 99.24 | 0.43 | 30.17 ± 0.42 | 99.74 | 1.39 |
| 60.50 | 60.13 ± 2.10 | 99.39 | 3.49 | 61.02 ± 1.95 | 100.86 | 3.20 | |
| 121.00 | 120.04 ± 2.29 | 99.21 | 1.91 | 120.11 ± 2.25 | 99.26 | 1.87 | |
| Lucidenic acid E2 | 29.75 | 30.33 ± 0.12 | 101.95 | 0.40 | 30.12 ± 0.50 | 101.24 | 1.66 |
| 59.50 | 60.17 ± 0.97 | 101.13 | 1.61 | 58.27 ± 0.79 | 97.93 | 1.36 | |
| 119.00 | 118.56 ± 1.96 | 99.63 | 1.65 | 118.39 ± 0.96 | 99.49 | 0.81 | |
| Ganoderic acid A | 30.75 | 30.28 ± 1.11 | 98.47 | 3.67 | 30.10 ± 0.59 | 97.89 | 1.96 |
| 61.50 | 60.00 ± 1.05 | 97.56 | 1.75 | 59.88 ± 0.88 | 97.37 | 1.47 | |
| 123.00 | 122.12 ± 1.27 | 99.28 | 1.04 | 121.16 ± 2.05 | 98.50 | 1.69 | |
| Ganoderic acid E | 29.75 | 29.59 ± 0.59 | 99.46 | 1.99 | 29.03 ± 0.76 | 97.58 | 2.62 |
| 59.50 | 59.27 ± 1.12 | 99.61 | 1.89 | 58.36 ± 0.99 | 98.08 | 1.70 | |
| 119.00 | 118.33 ± 0.95 | 99.44 | 0.80 | 118.13±1.13 | 99.27 | 0.96 | |
| Methyl lucidenate E2 | 28.75 | 27.94 ± 0.84 | 97.18 | 3.01 | 29.13 ± 0.89 | 101.32 | 3.06 |
| 57.50 | 58.24 ± 1.10 | 101.29 | 1.89 | 56.02 ± 0.93 | 97.43 | 1.66 | |
| 115.00 | 116.05 ± 1.27 | 100.91 | 1.09 | 114.12 ± 2.11 | 99.23 | 1.85 | |
| Methyl lucidenate A | 31.75 | 29.62 ± 0.66 | 93.29 | 2.23 | 30.59 ± 0.73 | 96.35 | 2.39 |
| 63.50 | 62.21 ± 0.98 | 97.97 | 1.58 | 62.58 ± 1.06 | 98.55 | 1.69 | |
| 127.00 | 125.76 ± 0.74 | 99.02 | 0.59 | 126.29 ± 1.94 | 99.44 | 1.54 | |
| Butyl lucidenate E2 | 33.75 | 29.45 ± 0.58 | 87.26 | 1.97 | 32.19 ± 0.82 | 95.38 | 2.55 |
| 67.50 | 66.54 ± 1.20 | 98.58 | 1.80 | 66.83 ± 1.02 | 99.01 | 1.53 | |
| 135.00 | 133.50 ± 1.31 | 98.89 | 0.98 | 134.20 ± 2.07 | 99.41 | 1.54 | |
| Lucidadiol | 32.50 | 30.08 ± 0.69 | 92.55 | 2.29 | 32.19 ± 0.83 | 99.05 | 2.58 |
| 65.00 | 63.89 ± 1.01 | 98.29 | 1.58 | 63.97 ± 1.32 | 98.42 | 2.06 | |
| 130.00 | 128.95 ± 1.17 | 99.19 | 0.91 | 128.04 ± 1.95 | 98.49 | 1.52 | |
| Ganodemanontriol | 30.75 | 29.85 ± 0.58 | 97.07 | 1.94 | 29.83 ± 0.59 | 97.01 | 1.98 |
| 61.50 | 61.59 ± 0.94 | 100.15 | 1.53 | 60.82 ± 0.83 | 98.89 | 1.36 | |
| 123.00 | 122.11 ± 1.27 | 99.28 | 1.04 | 122.39 ± 1.96 | 99.50 | 1.60 | |
| Ganoderiol F | 29.25 | 29.78 ± 0.55 | 101.81 | 1.85 | 29.89 ± 0.55 | 102.19 | 1.84 |
| 58.50 | 58.02 ± 1.01 | 99.18 | 1.74 | 58.01 ± 1.03 | 99.16 | 1.78 | |
| 117.00 | 115.38 ± 1.78 | 98.62 | 1.54 | 116.12 ± 2.11 | 99.25 | 1.82 | |
| Ganodermadiol | 30.25 | 30.05 ± 0.73 | 99.34 | 2.43 | 30.11 ± 0.49 | 99.54 | 1.63 |
| 60.50 | 60.02 ± 0.79 | 99.21 | 1.32 | 60.12 ± 1.37 | 99.37 | 2.28 | |
| 121.00 | 120.11 ± 1.02 | 99.26 | 0.85 | 120.37 ± 2.05 | 99.48 | 1.70 | |
| Ergosterol | 29.75 | 30.67 ± 0.63 | 103.09 | 2.05 | 30.17 ± 0.73 | 101.41 | 2.42 |
| 59.50 | 58.03 ± 0.92 | 97.53 | 1.59 | 59.20 ± 1.52 | 99.50 | 2.57 | |
| 119.00 | 119.97 ± 1.12 | 100.82 | 0.93 | 118.79 ± 1.99 | 99.82 | 1.68 | |
Contents of 4–17 in the wild collected Linhzhi samples (Group A).
| Compounds | Content (µg/g) a | |||||
|---|---|---|---|---|---|---|
| VN1 | VN12 | VN13 | VN16 | VN18 | VN21 | |
| Lucidenic acid N ( | 388.16 ±5.10 | 444.58 ± 3.84 | 845.46 ± 9.89 | 420.71 ± 2.40 | 257.80 ± 3.88 | 884.05 ± 7.45 |
| Lucidenic acid E2 ( | 776.90 ± 9.83 | 1766.75 ± 24.01 | 319.47 ± 6.93 | 1151.08 ± 7.64 | 430.79 ± 7.04 | 1695.01 ± 16.32 |
| Ganoderic acid A ( | 228.88 ± 3.12 | 401.93 ± 2.37 | 349.93 ± 5.05 | 140.97 ± 1.71 | 891.05 ± 7.68 | 509.76 ± 7.05 |
| Ganoderic acid E ( | 878.27 ± 7.75 | 1528.73 ± 12.88 | 574.54 ± 4.71 | 797.83 ± 18.76 | 2100.20 ± 13.11 b | 1614.25 ± 9.27 |
| Methyl lucidenate E2 ( | − | − | − | − | − | − |
| Methyl lucidenate A ( | 46.62 ± 1.47 | − | − | − | − | − |
| Butyl lucidenate E2 ( | − | − | − | − | − | − |
| Lucidadiol ( | 144.44 ± 2.32 | 212.81 ± 1.35 | 111.31 ± 1.00 | 128.84 ± 0.54 | 243.95 ± 6.43 | 219.25 ± 2.00 |
| Ganodemanontriol ( | 168.35 ± 2.53 | 364.27 ± 3.33 | 232.15 ± 1.82 | 129.31 ± 0.95 | 394.10 ± 5.78 | 291.04 ± 2.44 |
| Ganoderiol F ( | 697.42 ± 13.75 | 643.68 ± 11.49 | 795.69 ± 5.07 | 563.94 ± 2.86 | 1635.06 ± 13.63 | 689.01 ± 2.02 |
| Ganodermadiol ( | 218.99 ± 4.14 | 159.87 ± 0.95 | 91.38 ± 1.03 | 95.33 ± 0.60 | 225.56 ± 0.49 | 348.52 ± 4.90 |
(−): Lower than test limit and could not be quantified; a Data were expressed as mean ± SD of three experiments; b Out of linear range.
Contents of 4–17 in the cultivated Linhzhi samples (Group B).
| Compounds | Content (µg/g) a | |||
|---|---|---|---|---|
| GL1 | GL2 | GL3 | VN10 | |
| Lucidenic acid N ( | 139.08 ± 1.82 | − | 79.58 ± 1.47 | 52.53 ± 1.06 |
| Lucidenic acid E2 ( | 481.31 ± 4.07 | 420.91 ± 2.78 | 357.89 ± 2.90 | 258.06 ± 1.31 |
| Ganoderic acid A ( | 83.35 ± 2.40 | 232.55 ± 5.66 | 70.17 ± 0.66 | 76.19 ± 0.18 |
| Ganoderic acid E ( | 730.00 ± 4.27 | 85.54 ± 0.89 | 207.77 ± 1.79 | 773.92 ± 4.75 |
| Methyl lucidenate E2 ( | 286.94 ± 2.33 | 446.45 ± 8.63 | 288.41 ± 1.73 | − |
| Methyl lucidenate A ( | − | − | − | − |
| Butyl lucidenate E2 ( | − | − | − | − |
| Lucidadiol ( | 69.15 ± 1.40 | 49.43 ± 0.69 | 109.00 ± 1.00 | 50.47 ± 1.59 |
| Ganodemanontriol ( | 107.04 ± 3.32 | 208.34 ± 2.62 | 50.85 ± 0.80 | |
| Ganoderiol F ( | 86.16 ± 1.24 | 65.03 ± 0.71 | 153.75 ± 0.92 | 226.71 ± 1.29 |
| Ganodermadiol ( | 59.59 ± 0.60 | 78.23 ± 0.64 | 37.07 ± 0.41 | |
(−): Lower than test limit and could not be quantified; a Data were expressed as mean ± SD of three experiments.
Contents of 4–17 in the related Linzhi samples (Group C).
| Compounds | Content (µg/g) a | ||||
|---|---|---|---|---|---|
| TGLs | TGap | TGau | TGc | TGs | |
| Lucidenic acid N ( | 144.18 ± 1.15 | − | 63.13 ± 1.45 | 207.73 ± 2.05 | 57.50 ± 0.65 |
| Lucidenic acid E2 ( | 413.76 ± 2.04 | − | 121.65 ± 4.50 | 201.92 ± 2.45 | − |
| Ganoderic acid A ( | 89.18 ± 0.97 | − | 78.09 ± 2.97 | 118.24 ± 3.09 | − |
| Ganoderic acid E ( | 475.23 ± 3.28 | 114.89 ± 1.89 | 1213.14 ± 15.26 | 337.62 ± 4.91 | 51.10 ± 1.30 |
| Methyl lucidenate E2 ( | − | 2499.52 ± 17.65 | 18,247.10 ± 48.40 b | 1023.84 ± 28.71 | − |
| Methyl lucidenate A ( | − | − | 144.89 ± 3.34 | − | − |
| Butyl lucidenate E2 ( | − | − | 65.65 ± 0.65 | − | − |
| Lucidadiol ( | 54.04 ± 1.32 | 70.36 ± 0.06 | 98.44 ± 1.19 | 46.08 ± 0.78 | − |
| Ganodemanontriol ( | − | 72.99 ± 1.88 | − | ||
| Ganoderiol F ( | 84.61 ± 0.85 | − | 126.42 ± 1.32 | 272.73 ± 3.49 | 56.58 ± 0.70 |
| Ganodermadiol ( | − | − | 47.55 ± 0.71 | ||
(−): Lower than test limit and could not be quantified; a Data were expressed as mean ± SD of three experiments; b Out of linear range.
Figure 3Content of 4–17 in various Linhzhi samples belong to groups A, B and C.